2024년 3월 19일
Advancing Health: Ildong Bioscience's Cholesterol Reduction Postbiotic Ingredient Gains Self-Affirmed GRAS Status
In a significant development within the health functional food industry, Ildong Bioscience, a branch of the Ildong Pharmaceutical Group, has attained a major regulatory milestone. The company announced on March 19 that its postbiotic raw materials had been granted the "self-affirmed Generally Recognized as Safe (GRAS)" status in the United States.
Achieving self-affirmed GRAS status is essential for companies aiming to introduce new ingredients into the U.S. market. This status results from extensive safety assessments conducted by experienced experts and toxicologists under the U.S. Food and Drug Administration (FDA) oversight. Such rigorous evaluations ensure the raw materials meet the highest safety standards.
The "BBR4401 heat treatment culture dry" postbiotic from Ildong Bioscience was the focus of this GRAS status. This development is a testament to the company's commitment to providing safe and high-quality ingredients to the market.
This latest achievement increases Ildong Bioscience's portfolio of self-affirmed GRAS materials to 21, bolstering its position in the international market for postbiotic raw materials.
A spokesperson for Ildong Bioscience highlighted the significance of this GRAS status, underlining the company's dedication to safety and quality in their offerings.
Ildong Bioscience is also pursuing additional certifications, like Health Canada's Natural Product Number (NPN) and HALAL certification, to further enhance and differentiate its postbiotic materials globally.
Founded in 2016 from Ildong Pharmaceutical, Ildong Bioscience has established itself in the health functional food industry. The company continues to innovate, launching various products and brands and providing raw material supply and OEM and ODM services to top-tier companies worldwide, thereby affirming its status in the health and wellness industry.